The Phase I trial of BMP-7 showed a trend to a symptom response for knee OA with a lack of dose-limiting toxicity [ 48 ].
← all excerpts
Sustained delivery of the bone morphogenetic proteins BMP-2 and BMP-7 for cartilage repair and regeneration in osteoarthritis.
1
—
—